HilleVax, Inc. [Rocket]

Date	Name	Title	Type	Security	Shares	Price	Value	Ownership	Reported
06/07/2023	Gerberding Julie L.	Director	Grant	Stock Option	22.5k	$17.94	$403.6k		06/07/2023
06/07/2023	Sepulveda Jaime	Director	Grant	Stock Option	22.5k	$17.94	$403.6k		06/07/2023
06/07/2023	Cocero Nanette	Director	Grant	Stock Option	11k	$17.94	$197.3k		06/07/2023
06/07/2023	Chu Shelley	Director	Grant	Stock Option	22.5k	$17.94	$403.6k		06/07/2022
06/07/2023	Heron Patrick J	10% Owner	Grant	Stock Option	22.5k	$17.94	$403.6k		06/07/2023
06/07/2023	HILLEMAN JERYL L	Director	Grant	Stock Option	22.5k	$17.94	$403.6k		06/07/2023
05/08/2023	Cocero Nanette	Director	Grant	Stock Option (Right to Buy)	34k	$14.20	$482.8k		05/08/2023
11/30/2022	TAKEDA PHARMACEUTICAL CO LTD	10% Owner	Exercise (in-the-money or at-the-money)	Common Stock	5.9M	$0.00	$0	See Explanation of Responses	11/30/2022
11/30/2022	TAKEDA PHARMACEUTICAL CO LTD	10% Owner	Exercise (in-the-money or at-the-money)	Warrant (Right to Buy)	5.9M	$0.00	$588.4	See Explanation of Responses	11/30/2022
08/19/2022	Heron Patrick J	10% Owner	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
08/19/2022	Gerberding Julie L.	Director	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
08/19/2022	Silbermann Susan Michele	Director	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
08/19/2022	Chu Shelley	Director	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
08/19/2022	HILLEMAN JERYL L	Director	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
08/19/2022	Sepulveda Jaime	Director	Grant	Stock Option	25k	$12.38	$309.5k		08/19/2022
05/03/2022	Frazier Life Sciences X, L.P.	10% Owner	Purchase	Common Stock	1.8M	$17.00	$30M		05/03/2022
05/03/2022	Frazier Life Sciences X, L.P.	10% Owner	Conversion	Common Stock	2.7M	$13.60	$37.2M		05/03/2022
05/03/2022	Frazier Life Sciences X, L.P.	10% Owner	Conversion	Convertible Promissory Notes	37.2M	$13.60	$506.1M		05/03/2022